ScholarIQanswers from OpenAlex

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

PaperCitations, authors & open-access status

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy have?

ScholarIQcitation count

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy has 58 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy published?

ScholarIQyear

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy has 2023 year in the ScholarIQ index.

What is the open-access status of Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy?

ScholarIQoa status

Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy has hybrid oa status in the ScholarIQ index.

What is the DOI of Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy?

ScholarIQdoi

The DOI for Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy is on the source record.

What is the PMID of Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy?

ScholarIQpmid

The PMID for Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy is on the source record.

What is the OpenAlex record for Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy?

ScholarIQopenalex

The OpenAlex for Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial